Nutrien Q1 2024 Adj EPS $0.46 Beats $0.37 Estimate, Sales $5.389B Beat $5.315B Estimate
Portfolio Pulse from Benzinga Newsdesk
Nutrien (NYSE:NTR) reported Q1 2024 adjusted EPS of $0.46, surpassing the $0.37 estimate, with sales of $5.389B also beating the $5.315B estimate. This represents a 11.76% decrease in sales compared to the same period last year.

May 08, 2024 | 9:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nutrien's Q1 2024 earnings exceeded expectations with an adjusted EPS of $0.46 against a $0.37 estimate and sales surpassing forecasts at $5.389B.
Beating both EPS and sales estimates typically generates positive investor sentiment, likely leading to a short-term uptick in Nutrien's stock price. However, the year-over-year decrease in sales might temper some of the positive momentum.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100